1.
|
Phase: Phase III Type: Prevention Status: Active Age: 40 to 80 Sponsor: NCI, Other Protocol IDs: CDR0000353185, P30CA023074, UARIZ-00-0430-01, UARIZ-HSC-00142, P01CA041108, 00-0430-01, NCT00078897
|
|
2.
|
Phase: Phase III Type: Natural history/Epidemiology, Prevention Status: Active Age: 50 and over Sponsor: NCI Protocol IDs: SWOG-S0000D, S0000D, NCT00706121
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000602239, UZG-CUL-UHG-Non-InvasiveBladde, EU-20870, UZG-CUL-UHG-Non-InvasiveBladderCancer, CUL-UHG-Non-Invasive Bladder Cancer, NCT00729287
|
|
4.
|
Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: HORCSCT-9001, NCT01432873
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Dietary intervention FL, NCT00455416
|
|
6.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-0580-B, NCT00744549
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-0604-CE, NCT00844792
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Approved-not yet active Age: 50 and over Sponsor: Other Protocol IDs: 2008-1122, NCT01211561
|